富血小板血浆
医学
间充质干细胞
肩袖
肌腱
软骨
骨关节炎
骨髓
干细胞
再生(生物学)
骨髓抽出物
外科
血小板
病理
内科学
解剖
生物
细胞生物学
替代医学
作者
Carlos Leal,Jorge Chahla,Luciano Andrés Rossi,Nicolás S. Piuzzi
出处
期刊:PubMed
日期:2024-01-01
卷期号:73: 3-13
摘要
The use of orthobiologics such as platelet-rich plasma, bone marrow aspirate, and stem cells has been proposed as a biologic augmentation for treatment of various conditions of cartilage, tendon, and bone. Although the published evidence is not conclusive, the safety of these treatments and benefits in improving the biologic condition of treated tissues have been confirmed. Osteoarthritis, rotator cuff injuries, and osteonecrosis of the femoral head are three common musculoskeletal conditions associated with the use of orthobiologics in patients with cartilage, tendon, and bone injuries. When reviewing the use of platelet-rich plasma, bone marrow aspirate, and mesenchymal stem cells in patients with these conditions, there is evidence of high safety and positive, but variable, efficacy. Recent studies have shown promising results and have paved the way for research being conducted at many specialized centers around the world.
科研通智能强力驱动
Strongly Powered by AbleSci AI